Literature DB >> 21153039

FDG-PET/CT of polymyalgia rheumatica.

Takuya Kotani, Tsuyoshi Komori, Yumiko Kanzaki, Tohru Takeuchi, Daisuke Wakura, Akio Iimori, Suzue Hirano-Kuwata, Shigeki Makino, Toshiaki Hanafusa, Akira Ukimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21153039     DOI： 10.1007/s10165-010-0382-7

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


× No keyword cloud information.
  4 in total

1.  Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.

Authors:  X Palard-Novello; S Querellou; M Gouillou; A Saraux; T Marhadour; F Garrigues; R Abgral; P Y Salaün; V Devauchelle-Pensec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-11       Impact factor: 9.236

2.  Comment on: FDG PET in the early diagnosis of large-vessel vasculitis.

Authors:  Zdeněk Rehák; Petr Szturz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

3.  Positron emission tomography findings in a patient with multiple myeloma of polymyalgia rheumatica-like symptoms caused by paraneoplastic syndrome.

Authors:  Shingo Suzuki; Masatomi Ikusaka; Masahito Miyahara; Kiyoshi Shikino
Journal:  BMJ Case Rep       Date:  2014-04-09

4.  PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis.

Authors:  Zdenek Rehak; Andrea Sprlakova-Pukova; Zbynek Bortlicek; Zdenek Fojtik; Tomas Kazda; Marek Joukal; Renata Koukalova; Jiri Vasina; Jana Eremiasova; Petr Nemec
Journal:  Radiol Oncol       Date:  2017-01-14       Impact factor: 2.991
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.